Similar to all other states, over December and January 2021 was highly challenging with case numbers reaching over 100 times their previous daily records. ACT needed a fast solution to be able to conduct mass screening and minimise new infections.
The MP Bio test kit with its superior sensitivity was selected by ACT Health to roll out mass screening programs amongst the public. Due to its simplicity yet its high efficacy at over 98% sensitivity and 100% specificity, the MP Biomedicals test was an ideal product for the purpose.
Westlab worked closely with ACT Health and our supply chain partners Santé Group, leveraging global allocations of the MP Biomedicals test to ensure ACT could get a timely delivery and full allocations for their needs.
Working with Santé brought a highly secure supply chain from production right through to delivery and consumption.